BIOG-B:STO
BioGaia AB
SEK 116,80
arrow_upward
+1,21%(+1,40) 1D
9 ຕ.ລ., 17 ໂມງ 29 ນາທີ 57 ວິນາທີ GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIOG-B...
Open
SEK 116,20
High
SEK 117,90
Low
SEK 116,00
Mkt. cap
11,50 ຕື້
Avg. vol.
162,09 ພັນ
Volume
58,09 ພັນ
52-wk high
SEK 136,30
52-wk low
SEK 96,20
Shares outstanding
98,50 ລ້ານ
No. of employees
251
Open
SEK 116,20
High
SEK 117,90
Low
SEK 116,00
Mkt. cap
11,50 ຕື້
Avg. vol.
162,09 ພັນ
Volume
58,09 ພັນ
52-wk high
SEK 136,30
52-wk low
SEK 96,20
Shares outstanding
98,50 ລ້ານ
No. of employees
251
News stories
From web sources and news partners
TipRanks
·
1 ມື້ກ່ອນ
BioGaia Sets October 22 Date for Q3 2026 Results and Investor Briefing
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB